Bilde av Kranz, Mathias
Bilde av Kranz, Mathias
Forsker Medisiinnalaš biologiija instituhtta mathias.kranz@uit.no Tromsø You can find me here

Mathias Kranz



  • Ursula Søndergaard, Thomas Kolle Ekaney, Kristina Søborg Pedersen, Mathias Kranz, Rune Sundset, Angel Moldes-Anaya et al.:
    Production of 67Cu at a biomedical cyclotron via 70Zn(p,α)67Cu reaction and its evaluation in a preclinical study using small animal SPECT/CT
    Applied Radiation and Isotopes 2025 DOI
  • Kjersti Sellæg, Ruth Schwienbacher, Mathias Kranz, Anna Engan Aamodt, Anna Maria Wirsing, gerd Berge et al.:
    4-nitroquinoline 1-oxide-induced oral epithelial lesions exhibit time- and stage-dependent changes in the tumor immune microenvironment
    Frontiers in Oncology 2024 DOI / ARKIV
  • Piyapan Suwattananuruk, Sukanya Yaset, Chanisa Chotipanich, Angel Moldes-Anaya, Rune Sundset, Rodrigo Berzaghi et al.:
    Radiosynthesis and preclinical evaluation of a 68Ga-labeled tetrahydroisoquinoline-based ligand for PET imaging of C-X-C chemokine receptor type 4 in an animal model of glioblastoma
    EJNMMI Radiopharmacy and Chemistry 2024 DOI / ARKIV
  • Shaheen Syed, Kathryn Elizabeth Anderssen, Svein Kristian Stormo, Mathias Kranz :
    Weakly supervised semantic segmentation for MRI: exploring the advantages and disadvantages of class activation maps for biological image segmentation with soft boundaries
    Scientific Reports 2023 DOI / ARKIV
  • Samuel Ortega, Ragni Ofstad, Shaheen Syed, Mathias Kranz, Karsten Heia, Kathryn Elizabeth Anderssen :
    Characterization of vasskveite (water halibut) syndrome for automated detection
    Applied Food Research 2023 DOI / ARKIV
  • Susannah von Hofsten, Marianne Hagensen Paulsen, Synnøve Magnussen, Dominik Ausbacher, Mathias Kranz, Annette Bayer et al.:
    The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines
    Scientific Reports 2022 DOI / ARKIV
  • Marcel Lindemann, Ana Oteiza, Montserrat Martin-Armas, Yngve Guttormsen, Angel Moldes-Anaya, Rodrigo Berzaghi et al.:
    Glioblastoma PET/MRI: kinetic investigation of [18F]rhPSMA-7.3, [18F]FET and [18F]fluciclovine in an orthotopic mouse model of cancer
    European Journal of Nuclear Medicine and Molecular Imaging 2022 DOI / ARKIV
  • Kathryn Elizabeth Anderssen, Mathias Kranz, Shaheen Syed, Svein Kristian Stormo :
    Diffusion tensor imaging for spatially-resolved characterization of muscle fiber structure in seafood
    Food Chemistry 2022 DOI / ARKIV
  • Kathryn Elizabeth Anderssen, Geir W. Gabrielsen, Mathias Kranz, France Collard :
    Magnetic resonance imaging for non-invasive measurement of plastic ingestion in marine wildlife
    Marine Pollution Bulletin 2022 DOI / ARKIV
  • Juliane Weiner, Lisa Roth, Mathias Kranz, Peter Brust, Anita Boelen, Nora Klöting et al.:
    Leptin counteracts hypothermia in hypothyroidism through its pyrexic effects and by stabilizing serum thyroid hormone levels
    Molecular Metabolism 2021 DOI
  • Thu Hang Lai, Magali Toussaint, Rodrigo Teodoro, Sladjana Dukić-Stefanović, Mathias Kranz, Winnie Deuther-Conrad et al.:
    Synthesis and biological evaluation of a novel 18F-labeled radiotracer for PET imaging of the adenosine A2A receptor
    International Journal of Molecular Sciences 25. Jan 2021 DOI / ARKIV
  • Thu Hang Lai, Susann Schröder, Magali Toussaint, Sladjana Dukić-Stefanović, Mathias Kranz, Friedrich-Alexander Ludwig et al.:
    Development of 8f-labeled radiotracers for pet imaging of the adenosine a2a receptor: Synthesis, radiolabeling and preliminary biological evaluation
    International Journal of Molecular Sciences 2021 DOI / ARKIV
  • Magali Toussaint, Winnie Deuther-Conrad, Mathias Kranz, Steffen Fischer, Friedrich-Alexander Ludwig, Tareq A. Juratli et al.:
    Sigma-1 receptor positron emission tomography: A new molecular imaging approach using (S)-(-)-[18F]fluspidine in glioblastoma
    Molecules 06. May 2020 DOI / ARKIV
  • Bernhard Sattler, Mathias Kranz, Barbara Wenzel, Nalin T. Jain, Rareş-Petru Moldovan, Magali Toussaint et al.:
    Preclinical incorporation dosimetry of [18F]FACH—A novel 18F-labeled MCT1/MCT4 lactate transporter inhibitor for imaging cancer metabolism with PET
    Molecules 2020 DOI / ARKIV
  • Susann Schröder, Thu Hang Lai, Magali Toussaint, Mathias Kranz, Alexandra Chovsepian, Qi Shang et al.:
    PPET imaging of the adenosine A2A receptor in the rotenone-based mouse model of Parkinson’s disease with [18F]FESCH synthesized by a simplified two-step one-pot radiolabeling strategy
    Molecules 2020 DOI / ARKIV
  • Rien Ritawidya, Barbara Wenzel, Rodrigo Teodoro, Magali Toussaint, Mathias Kranz, Winnie Deuther-Conrad et al.:
    Radiosynthesis and biological investigation of a novel fluorine-18 labeled benzoimidazotriazine- based radioligand for the imaging of phosphodiesterase 2A with positron emission tomography
    Molecules 2019 DOI / ARKIV
  • Turid Hellevik, Kristin Lode, Sindhu Kancherla, Yngve Guttormsen, Rodrigo Berzaghi, Vera Maia et al.:
    Preclinical assessment of [18F]AIF-FAPI for PET-imaging of cancer-associated fibroblast responses to radiotherapy
    2025
  • Turid Hellevik, Kristin Lode, Sindhu Kancherla, Yngve Guttormsen, Rodrigo Berzaghi, Vera Maia et al.:
    Preclinical evaluation of [18F]AIF-FAPI-74 PET-imaging as biomarker for monitoring cancer-associated fibroblast responses to radiotherapy
    2025
  • Turid Hellevik, Kristin Lode, Sindhu Kancherla, Yngve Guttormsen, Rodrigo Berzaghi, Vera Maia et al.:
    Exploring the effects of radiotherapy on cancer-associated fibroblasts by non-invasive PET-imaging
    2025
  • Margrethe Similä Vasslag, Kjersti Sellæg, Morten Bøhmer Strøm, Stine Figenschau, Rodrigo Berzaghi, Mathias Kranz et al.:
    Intratumoral treatment of glioblastoma in mice using the novel compound MPM-1
    2025
  • Karoline Nordli, Hanna Bähr, Mathias Kranz, Angel Moldes-Anaya, Jørn H Hansen :
    Towards a Novel Radiotracer for PET – Imaging of Glioblastoma Targeting the Notch Signaling Pathway
    2023
  • Karoline Nordli, Hanna Bähr, Angel Moldes-Anaya, Jørn H Hansen, Mathias Kranz :
    Towards a novel radiotracer for PET – imaging of glioblastoma targeting the Notch signaling pathway
    2022
  • Yngve Guttormsen, Angel Moldes-Anaya, Richard Fjellaksel, Ana Oteiza, Montserrat Martin-Armas, Marcel Lindemann et al.:
    Development of a carbon-11 labeled thienopyrimidine based radioligand for EGFR-tyrosine-kinase-inhibitor (TKI) specific PET imaging of glioblastoma
    Journal of Nuclear Medicine 2021
  • Yngve Guttormsen, Mathias Kranz, Richard Fjellaksel, Montserrat Martin-Armas, Ana Oteiza, Julia Bihler et al.:
    SP-015 - Preliminary evaluation of a novel carbon-11 labeled brain-penetrant EGFR-TKI radiotracer for brain cancer imaging
    Nuclear Medicine and Biology 2021 DOI

  • The 50 latest publications is shown on this page. See all publications in Cristin here →



    MH øst L8.226E


    Click for bigger map



    Attachments: